Mapping the world

The CIRS Regulatory and Reimbursement Atlas™ offers the following maps:

  • Australia
  • Austria
  • Belgium
  • Brazil
  • Bulgaria
  • China
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • England: NAS; Devices
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Japan
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Scotland
  • Singapore
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • USA: CMS (medicare/medicaid)
  • Wales
  • Canada: CDR and pCODR
  • Canada, Alberta: NAS; Onc; Devices
  • Canada, British Columbia: NAS; Onc; Devices
  • Canada, Manitoba: NAS; Onc
  • Canada, New Brunswick: NAS; Onc
  • Canada, Newfoundland and Labrador: NAS; Onc
  • Canada, Northwest Territories: NAS; Onc
  • Canada, Nova Scotia: NAS; Onc
  • Canada, Nunavut: NAS; Onc
  • Canada, Ontario: NAS; Onc; Devices
  • Canada, Prince Edward Island: NAS; Onc
  • Canada, Quebec: NAS and Onc
  • Canada, Saskatchewan: NAS; Onc
  • Canada, Yukon: NAS; Onc

 

CDR=Common Drug Review; NAS=new active substances; Onc=Oncology; pCODR=panCanadian Oncology Drug Review.

All maps listed are for NAS unless otherwise indicated.